Clinical Trial Update: Dosing of Intra-articular Triamcinolone Hexacetonide for Knee Synovitis in Chronic Polyarthritis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on dosing of intra-articular Triamcinolone hexacetonide for knee synovitis in chronic polyarthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthritis of the Knee

Drugs mentioned

• Triamcinolone hexacetonide (triamcinolone hexacetonide)

Snippet

Sponsor: Uppsala University | Conditions: Arthritis of the Knee | Phase 4 | Status: UNKNOWN